The adoption of surfactant replacement therapy (SRT) for the treatment of neonatal respiratory distress syndrome (nRDS) is one of the main contributors to the dramatic decline in infant mortality rates observed in the 1980s. Despite the significant efficacy of animal-derived surfactant preparations, there are still some concerns associated with their...